- ►nih.gov MS Spitzer, B Wallenfels-Thilo, A Sierra, E … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Methods: Monolayer cultures of ARPE19, RGC5, and CEC were used. Bevacizumab
(0.008–2.5 mg/ml), diluted in culture medium, was added to cells that were
growing on cell culture dishes. Cellular proliferative activity was ... Cited by 37 - Related articles - BL Direct - All 8 versions
- ►nih.gov M Lüke, M Warga, F Ziemssen, F Gelisken, S … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Background: Bevacizumab (Avastin) is a recombinant protein that targets vascular
endothelial growth factor (VEGF). In vitro, bevacizumab inhibits VEGF induced
cell proliferation and tissue factor production. Abnormal angiogenesis ... Cited by 35 - Related articles - BL Direct - All 7 versions
- ►duanesolution.com S Luthra, R Narayanan, LEA MARQUES, M … - Retina, 2006 - journals.lww.com There was no significant difference (P 0.05) between viabilities of HMVECad
cells treated with bevacizumab and IgG. Conclusion: This study suggests that
bevacizumab, at concentrations at or above the dose normally used in ... Cited by 62 - Related articles - BL Direct - All 6 versions
L Feiner, EE BARR, YB Shui, NM … - Retina, 2006 - journals.lww.com Skip Navigation Links Home > October 2006 - Volume 26 - Issue 8 > Safety of
Intravitreal Injection of Bevacizumab in Rabbit Ey... ... From the *Department
of Ophthalmology and Visual Sciences, Washington University School of ... Cited by 35 - Related articles - BL Direct - All 3 versions
MS Spitzer, E Yoeruek, A Sierra, B … - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Page 1. RETINAL DISORDERS Comparative antiproliferative and cytotoxic profile
of bevacizumab (Avastin), pegaptanib (Macugen) and ... Cited by 23 - Related articles - BL Direct - All 2 versions
- ►duanesolution.com A Iriyama, YN Chen, Y Tamaki, Y Yanagi - British Journal of Ophthalmology, 2007 - bjo.bmj.com Aim: Intravitreal injection of anti-vascular endothelial growth factor (VEGF)
antibody (bevacizumab, Avastin) has become one of the chief choices for the
treatment of macular oedema and neovascular age-related macular ... Cited by 16 - Related articles - BL Direct - All 6 versions
- ►iovs.org UU Inan, B Avci, T Kusbeci, B Kaderli, R Avci … - Investigative Ophthalmology & Visual Science, 2007 - ARVO METHODS. Twenty-four rabbits were divided into two groups, each with two
subgroups. The first group (groups 1 and 2) received 1.25 mg (0.05 mL)
intravitreal bevacizumab, and the second group (groups 3 and 4) received ... Cited by 26 - Related articles - BL Direct - All 3 versions
RAJK MATURI, LA BLEAU, DL WILSON - Retina, 2006 - journals.lww.com Skip Navigation Links Home > March 2006 - Volume 26 - Issue 3 >
Electrophysiologic Findings After Intravitreal Bevacizumab (... ... From the
Vitreo-retinal Service, Midwest Eye Institute, Indianapolis, Indiana. Cited by 106 - Related articles - BL Direct - All 2 versions
SJ Bakri, JD Cameron, CA McCannel, JS … - American journal of ophthalmology, 2006 - Elsevier Bevacizumab was injected into the vitreous of one eye of each of eight
Dutch-belted rabbits; the other eye served as a control. Four rabbits received a
dose of 1.25 mg/0.05 ml of bevacizumab intravitreally into one eye, and the ... Cited by 48 - Related articles - All 12 versions
- ►prsjournal.com J Shahar, RL Avery, G Heilweil, A Barak, E … - Retina, 2006 - journals.lww.com From the *Department of Ophthalmology, Tel-Aviv Medical Center, †Sackler
Faculty of Medicine, Tel-Aviv University, Israel; ‡Neuroscience Research
Institute, University of California, Santa Barbara; §California Retina ... Cited by 200 - Related articles - BL Direct - All 7 versions
